The surge of mpox in Africa: a call for action

著者: Jean B. Nachega, Nadia A. Sam‐Agudu, Dimie Ogoina, Placide Mbala‐Kingebeni, Francine Ntoumi, Emmanuel Nakouné, Richard Njouom, Rosamund F Lewis, Monica Gandhi, Philip J. Rosenthal, Angeli Rawat, Lindsay A. Wilson, Jason Kindrachuk, Laurens Liesenborghs, Edward J. Mills, Wolfgang Preiser, Anne W. Rimoin, Nancy J. Sullivan, Martine Peeters, Éric Delaporte, Cheryl Baxter, Lee H. Harrison, Michel P. Hermans, Emma L. Mohr, Gregg Gonsalves, Nicaise Ndembi, Alimuddin Zumla, Jean Jacques Muyembe-Tamfum - The Lancet 2024 被引用: 50

Mpox was previously thought to be a zoonotic disease endemic in parts of central, west, and east Africa; however, from 2022 to 2023, a large global outbreak of mpox from clade II monkeypox virus occurred, marking the first instance of sustained transmission outside of Africa since the first case of mpox in a human was identified in 1970.1 More recently, clade I monkeypox virus has been responsible for a growing outbreak in the Democratic Republic of the Congo, with evidence of sexual transmission suggesting the potential for global spread.